Emergence of hypervirulent mutants resistant to early clearance during systemic serotype 1 pneumococcal infection in

Abstract

Insights

Certain Streptococcus pneumoniae serotype 1 strains with spxB mutations are hypervirulent and evade early immune clearance by macrophages in both mice and patients.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Streptococcus pneumoniae serotype 1 is a significant cause of invasive disease.
  • Specific clonal complexes (CCs) of serotype 1 are linked to differing mortality rates, with CC217 associated with high mortality.

Purpose of the Study:

  • To investigate the mechanisms behind the high mortality associated with certain Streptococcus pneumoniae serotype 1 isolates.
  • To identify genetic factors contributing to virulence and host immune evasion.

Main Methods:

  • Evaluation of clinical isolates and mutants in various mouse models (wild-type, macrophage-depleted, neutrophil-depleted, SIGN-R1 knockout).
  • In vitro assays including THP-1 cell binding and phagocytosis, capsule measurements, hydrogen peroxide production, and viability.
  • Genetic analysis of large-colony variants identified mutations in the spxB gene.

Main Results:

  • Large-colony variants with spxB mutations were observed in invasive disease cases in both mice and patients.
  • spxB mutants exhibited increased virulence in wild-type mice and resistance to early host clearance.
  • spxB mutants were less efficiently phagocytosed by macrophages and caused more severe disease upon immune cell depletion.

Conclusions:

  • Hypervirulent spxB mutants of Streptococcus pneumoniae serotype 1 are selected during infection in both hosts and animal models.
  • These mutants possess resistance to early clearance mechanisms mediated by macrophages.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K